Protalix BioTherapeutics, Inc (PLX) insider trading

Every open-market stock purchase and sale by Protalix BioTherapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $101K over the last 12 months (1 buy).
  • Insiders sold $314 over the last 12 months (1 sale).
  • Last insider buy: Dror Bashan (CEO), $101K, 9 months ago.

Last 12 months: insiders bought $101K (1 buy) and sold $314 (1 sale). Last close $2.67 on Sep 4, 2026.

Recent PLX insider trades

DateInsiderTradeValue
Sep 3, 2026Gwen A Melincoff (Insider)Bought (not open market)—
Sep 3, 2026Zvi Shmuel Ben (Insider)Bought (not open market)—
Sep 3, 2026Christian Elze (Insider)Bought (not open market)—
Sep 3, 2026Yaron Naos (COO)Bought (not open market)—
Sep 3, 2026Dror Bashan (CEO)Bought (not open market)—
Sep 3, 2026Amos Bar-Shalev (Insider)Bought (not open market)—
Sep 3, 2026Amos Bar-Shalev (Insider)Bought (not open market)—
Sep 3, 2026Christian Elze (Insider)Bought (not open market)—
Sep 3, 2026Pol F Boudes (Insider)Bought (not open market)—
Sep 3, 2026Dror Bashan (CEO)Bought (not open market)—
Sep 3, 2026Yaron Naos (COO)Bought (not open market)—
Sep 3, 2026Eliot Forster (Insider)Bought (not open market)—
Sep 3, 2026Zvi Shmuel Ben (Insider)Bought (not open market)—
Sep 3, 2026Eliot Forster (Insider)Bought (not open market)—
Sep 3, 2026Gwen A Melincoff (Insider)Bought (not open market)—
Sep 3, 2026Pol F Boudes (Insider)Bought (not open market)—
Dec 19, 2025Dror Bashan (CEO)Bought$101K
Nov 18, 2025Amos Bar-Shalev (Insider)Sold$314

Who's trading PLX

Get free alerts when an insider at Protalix BioTherapeutics, Inc files a new trade →